Alison Culpan of the Association of the British Pharmaceutical Industry (ABPI) saidiiHealth and Sport Committee, Official Report, 21 January 2020, Col 39 it was hard to quantify how much a licence application for an additional indication may cost. She providedvLetter from the Association of the British Pharmaceutical Industry on Supply and Demand for Medic...